Skip to content

Cross-sectional Study of Anorectal Function and Quality of Life in Patients With Middle and Low Rectal Cancer

Cross-sectional Study of Anorectal Function and Quality of Life in Patients With Middle and Low Rectal Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04697303
Enrollment
600
Registered
2021-01-06
Start date
2020-10-26
Completion date
2021-03-28
Last updated
2021-04-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rectal Cancer

Brief summary

Understanding the quality of life and anorectal function changes in patients with middle and low rectal cancer after surgery can guide patients to recover after surgery and provide a valuable reference for surgeons in the selection of surgical methods. The purpose of this study is to: (1) Investigate the complication rate, recurrence and metastasis rate and survival of patients with middle and low rectal cancer. (2) QLQ-C30 and QLQ-CR29 questionnaires were used to assess the quality of life of patients with low- and middle-level rectal cancer at different periods after surgery. (3) Wexner constipation score and LARS syndrome score for anorectal function after operation for low rectal cancer. (4) The CIPE ejaculatory function score, IIEF-5 International Erectile Function Score, and FSFI-6 Female Sexual Function Index were used to assess the changes in sexual function of patients with low- and middle-position rectal cancer after surgery.

Interventions

OTHERanorectal function test

anorectal function test

Sponsors

Quan Wang
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
OTHER

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

1. Postoperative patients with middle rectal cancer 2. Postoperative patients with low rectal cancer

Exclusion criteria

(1)Patients refused to participate

Design outcomes

Primary

MeasureTime frameDescription
Overall survivalfive years after the operationdefined as time from the date of sugery to death

Secondary

MeasureTime frameDescription
QLQ-CR29Every three months after the operationthe score of Quality of life questionnaire QLQ-C29
WexnerEvery three months after the operationthe score of questionnaire Wexner
LARSEvery three months after the operationthe score of questionnaire LARS
QLQ-C30Every three months after the operationthe score of Quality of life questionnaire QLQ-C30
CIPEEvery three months after the operationthe score of questionnaire CIPE
FSFI-6Every three months after the operationthe score of questionnaire FSFI-6
IIEF-5Every three months after the operationthe score of questionnaire IIEF-5

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026